Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi lifts profit outlook as Dupixent sales surge 43%
Reuters
Fri, 07/29/22 - 09:51 am
Sanofi
earnings
Sanofi CEO Paul Hudson says his company is the Big Pharma 'least exposed' to generics this decade
Fierce Pharma
Thu, 07/28/22 - 12:23 pm
Sanofi
Paul Hudson
Pharma CEOs
generics
Sanofi rolls out new diversity program to hire Howard University grads
Fierce Biotech
Tue, 07/26/22 - 11:02 am
Sanofi
racial diversity
diversity
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Endpoints
Mon, 07/25/22 - 10:37 am
siRNA
China
Sanofi
Rona Therapeutics
Sanofi walks away from kidney disease therapy, leaving $25M in milestones out of reach for Regulus
Fierce Biotech
Tue, 07/19/22 - 10:21 am
Sanofi
kidney disease
Regulus
lademirsen
Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis
BioSpace
Thu, 07/14/22 - 11:49 am
Regeneron
Sanofi
Dupixent
pediatric
eosinophilic esophagitis
Sanofi offloads 17 brands to Neuraxpharm
Fierce Pharma
Tue, 07/12/22 - 10:57 am
Sanofi
CNS
Neuraxpharm
Sanofi jumpstarts effort to supply 30 'essential' drugs to lower-income countries
Endpoints
Tue, 07/5/22 - 11:47 pm
Sanofi
philanthropy
Regeneron completes acquisition of Sanofi’s stake in Libtayo
Pharmaceutical Business Review
Mon, 07/4/22 - 11:58 pm
Regeneron
Sanofi
Libtayo
cancer
FDA Partially Halts Sanofi’s BTK Inhibitor for Multiple Sclerosis, Myasthenia Gravis
Pharma Live
Thu, 06/30/22 - 10:59 am
Sanofi
multiple sclerosis
myasthenia gravis
FDA
tolebrutinib
clinical trials
clinical hold
With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US
Fierce Pharma
Wed, 06/29/22 - 05:24 pm
Sanofi
insulin
drug pricing
diabetes
Two for two: Sanofi snares twin European nods for enzyme replacement therapies
MedCity News
Tue, 06/28/22 - 05:42 pm
Sanofi
Europe
Xenpozyme
Nexviazyme
enzyme replacement
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool
Mon, 06/27/22 - 10:12 am
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Sanofi, GSK tout 72% Omicron efficacy in PhIII trial of next-gen, bivalent shot — with an eye to year-end rollout
Endpoints
Fri, 06/24/22 - 10:56 am
Sanofi
GSK
COVID-19
COVID-19 variants
clinical trials
vaccines
CDC's ACIP recommends higher dose, Seqirus, Sanofi flu vaccines in adults 65 and older
Endpoints
Thu, 06/23/22 - 07:55 pm
CDC
ACIP
vaccines
Seqirus
Sanofi
flu vaccines
Fluad
Fluzone
FluBlok
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
Yahoo/Benzinga
Mon, 06/13/22 - 10:32 am
Sanofi
GSK
vaccines
COVID-19
COVID-19 variants
clinical trials
Sanofi union members set strike date in Korea as wage negotiations stall: report
Fierce Pharma
Sun, 06/12/22 - 08:20 pm
Sanofi
South Korea
strike
unions
Following tie-up with Sanofi, transatlantic AI firm secures latest Big Pharma deal in nine-figure Bristol Myers pact
Endpoints
Wed, 06/8/22 - 11:07 pm
Owkin
artificial intelligence
Sanofi
Bristol Myers Squibb
FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children
Pharmaceutical Business Review
Wed, 06/8/22 - 10:44 am
Sanofi
Regeneron
FDA
pediatric
atopic dermatitis
Dupixent
Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers
BioSpace
Sun, 06/5/22 - 11:31 pm
Immunocore
Sanofi
clinical trials
SAR444245
skin cancer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »